Cargando…
Preliminary study on the effects of enrofloxacin, flunixin meglumine and pegbovigrastim on Mycoplasma bovis pneumonia
BACKGROUND: Mycoplasma bovis is a causative agent of disease in cattle causing many clinical conditions. Currently there are no commercial M. bovis vaccines in Europe and treatment is difficult with decreased antimicrobial susceptibility of M. bovis field isolates. Using an M. bovis calf infection m...
Autores principales: | Dudek, Katarzyna, Bednarek, Dariusz, Ayling, Roger D., Kycko, Anna, Reichert, Michał |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815429/ https://www.ncbi.nlm.nih.gov/pubmed/31655595 http://dx.doi.org/10.1186/s12917-019-2122-3 |
Ejemplares similares
-
The Effect of Pegbovigrastim Injection on Phagocytic and Oxidative Burst Activities of Peripheral Blood Granulocytes and Monocytes in Calves Challenged with Mycoplasma bovis
por: Dudek, Katarzyna, et al.
Publicado: (2022) -
Analysis of the Leukocyte Response in Calves Suffered from Mycoplasma bovis Pneumonia
por: Dudek, Katarzyna, et al.
Publicado: (2020) -
Mycoplasma bovis Infections—Occurrence, Diagnosis and Control
por: Dudek, Katarzyna, et al.
Publicado: (2020) -
Detection of flunixin in the urine of untreated pigs housed with pigs treated with flunixin meglumine at labeled doses()
por: Hairgrove, Thomas B, et al.
Publicado: (2019) -
Saponin-based Mycoplasma Bovis Vaccine Containing Lysozyme Dimer Adjuvant Stimulates Acute Phase Response in Calves
por: Dudek, Katarzyna, et al.
Publicado: (2018)